QA: Achaogen Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001301501_2018_Achaogen_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001301501, Achaogen Inc

  xvar xval
0 AssetsCurrent 178,406,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,810,000
3 remainder_Assets 3,855,000
4 LiabilitiesCurrent 36,903,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 28,206,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 165,629,500
9 ResearchAndDevelopmentExpense 129,878,330
10 remainder_Expenses 3,399,246
11 remainder_Revenues 26,839,414
12 remainder_NetIncome -4,144,654
13 remainder_ComprehensiveNetIncome 15,656
  yvar yval
0 Assets 197,071,000
1 Liabilities 65,109,000
2 Expenses 298,907,076
3 Revenues 26,839,414
4 StockholdersEquity 131,962,000
5 NetIncome -276,212,316
6 ComprehensiveNetIncome -276,204,488
7 BaseVar 296,043,400
8 EconomicCapitalRatiobeforeLimitedLiability 0.0875
9 EconomicCapitalRatio 1.50

Edgar->Model Mapping

Feature Distribution

Change over Time